Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10264)
All Articles published online
|
Publishing Process of This Article
|
Jan 26, 2020 (publication date) through Dec 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bai J, Chen WB, Zhang XY, Kang XN, Jin LJ, Zhang H, Wang ZY. HIF-2α regulates CD44 to promote cancer stem cell activation in triple-negative breast cancer via PI3K/AKT/mTOR signaling. World J Stem Cells 2020; 12(1): 87-99 [PMID: 32110277 DOI: 10.4252/wjsc.v12.i1.87] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v12/i1/87.htm |
| Number | Citing Articles |
| 1 |
Wentao Si, Chen Kan, Leisheng Zhang, Feifei Li. Role of RUNX2 in breast cancer development and drug resistance (Review). Oncology Letters 2023; 25(5) doi: 10.3892/ol.2023.13762
|
| 2 |
Jin‐Dan Kai, Liang‐Hao Cheng, Bin‐Feng Li, Kai Kang, Fei Xiong, Jing‐Chun Fu, Sheng Wang. MYH9 is a novel cancer stem cell marker and prognostic indicator in esophageal cancer that promotes oncogenesis through the PI3K/AKT/mTOR axis. Cell Biology International 2022; 46(12): 2085 doi: 10.1002/cbin.11894
|
| 3 |
Jiwei Zhang, Wenjuan Gan, Ru Peng, Lei Lu, Weiqing Lu, Jiamei Liu. Activation of the mTOR pathway promotes neurite growth through upregulation of CD44 expression. Journal of International Medical Research 2023; 51(6) doi: 10.1177/03000605231178510
|
| 4 |
Loredana G. Marcu, Leyla Moghaddasi, Eva Bezak. Cannot Target What Cannot Be Seen: Molecular Imaging of Cancer Stem Cells. International Journal of Molecular Sciences 2023; 24(2): 1524 doi: 10.3390/ijms24021524
|
| 5 |
Jianjie Li, Xiangmei Zhang, Xueliang Liu, Xiangmin Ma, Yanfang Wang, Yunjiang Liu. JARID2 activation by NFYA promotes stemness of triple-negative breast cancer cells through the PI3K/AKT pathway. Expert Review of Anticancer Therapy 2024; : 1 doi: 10.1080/14737140.2024.2394167
|
| 6 |
Yue Su, Bolun Zhang, Ruowei Sun, Wenfang Liu, Qubo Zhu, Xun Zhang, Rongrong Wang, Chuanpin Chen. PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application. Drug Delivery 2021; 28(1): 1397 doi: 10.1080/10717544.2021.1938756
|
| 7 |
Feng Ju, Manar M. Atyah, Nellie Horstmann, Sheraz Gul, Razi Vago, Christiane J. Bruns, Yue Zhao, Qiong-Zhu Dong, Ning Ren. Characteristics of the cancer stem cell niche and therapeutic strategies. Stem Cell Research & Therapy 2022; 13(1) doi: 10.1186/s13287-022-02904-1
|
| 8 |
Zhen Luo, Mingfu Tian, Ge Yang, Qiaoru Tan, Yubing Chen, Geng Li, Qiwei Zhang, Yongkui Li, Pin Wan, Jianguo Wu. Hypoxia signaling in human health and diseases: implications and prospects for therapeutics. Signal Transduction and Targeted Therapy 2022; 7(1) doi: 10.1038/s41392-022-01080-1
|
| 9 |
Yan Xu, Tao Hu, Huizhen Ding, Yi Yuan, Rui Chen. miR-485-5p alleviates obstructive sleep apnea syndrome with hypertension by inhibiting PI3K/AKT signaling pathway via downregulating HIF3A expression. Sleep and Breathing 2023; 27(1): 109 doi: 10.1007/s11325-022-02580-8
|
| 10 |
|
| 11 |
Guofang Chen, Binya Liu, Shasha Yin, Shuangdi Li, Yu’e Guo, Mengfei Wang, Kai Wang, Xiaoping Wan. Hypoxia induces an endometrial cancer stem-like cell phenotype via HIF-dependent demethylation of SOX2 mRNA. Oncogenesis 2020; 9(9) doi: 10.1038/s41389-020-00265-z
|
| 12 |
Xianjing Chu, Wentao Tian, Jiaoyang Ning, Gang Xiao, Yunqi Zhou, Ziqi Wang, Zhuofan Zhai, Guilong Tanzhu, Jie Yang, Rongrong Zhou. Cancer stem cells: advances in knowledge and implications for cancer therapy. Signal Transduction and Targeted Therapy 2024; 9(1) doi: 10.1038/s41392-024-01851-y
|
| 13 |
Ruhan A, Naoto Kunimura, Shoko Tominaga, Erika Hirata, Shunya Nishioka, Misato Uesugi, Rion Yamazaki, Hideto Ueki, Koichi Kitagawa, Masato Fujisawa, Toshiro Shirakawa. A recombinant adenovirus vector containing the synNotch receptor gene for the treatment of triple-negative breast cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1147668
|
| 14 |
Xiaoxu Wei, Yunhua Chen, Xianjie Jiang, Miao Peng, Yiduo Liu, Yongzhen Mo, Daixi Ren, Yuze Hua, Boyao Yu, Yujuan Zhou, Qianjin Liao, Hui Wang, Bo Xiang, Ming Zhou, Xiaoling Li, Guiyuan Li, Yong Li, Wei Xiong, Zhaoyang Zeng. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Molecular Cancer 2021; 20(1) doi: 10.1186/s12943-020-01288-1
|
| 15 |
Hoon Sik Choi, Young Shin Ko, Hana Jin, Ki Mun Kang, In Bong Ha, Hojin Jeong, Haa-Na Song, Hye Jung Kim, Bae Kwon Jeong. Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro. Molecules 2021; 26(17): 5118 doi: 10.3390/molecules26175118
|
| 16 |
Tuna Onal, Mustafa Oztatlici, Melike Ozgul-Onal, Hülya Birinci, Mahmud Kemal Ozbilgin, Vissun Sevinç Inan. Рапаміцин знижує експресію рецепторів гіалуронану в клітинних лініях раку молочної залози MCF-7 та MDA-MB-231. Practical oncology 2022; 4(3-4): 5 doi: 10.22141/2663-3272.4.3-4.2021.250854
|
| 17 |
Barbara Ruszkowska-Ciastek, Katarzyna Kwiatkowska, Dorinda Marques-da-Silva, Ricardo Lagoa. Cancer Stem Cells from Definition to Detection and Targeted Drugs. International Journal of Molecular Sciences 2024; 25(7): 3903 doi: 10.3390/ijms25073903
|
| 18 |
Tianshu Zhang, Huimin Zhou, Kexin Wang, Xiaowei Wang, Mengyan Wang, Wenxia Zhao, Xiaoming Xi, Yang Li, Meilian Cai, Wuli Zhao, Yanni Xu, Rongguang Shao. Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development. Biomedicine & Pharmacotherapy 2022; 147: 112616 doi: 10.1016/j.biopha.2022.112616
|
| 19 |
Amal Qattan. Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease. International Journal of Molecular Sciences 2020; 21(23): 8905 doi: 10.3390/ijms21238905
|
| 20 |
Jingjing Gu, Dandan Chen, Zhiqiang Li, Yongliang Yang, Zhaoming Ma, Guanhong Huang. Prognosis assessment of CD44+/CD24− in breast cancer patients: a systematic review and meta-analysis. Archives of Gynecology and Obstetrics 2022; 306(4): 1147 doi: 10.1007/s00404-022-06402-w
|
| 21 |
Shichun Wang, Pengyu Zhang, Ekansh Mittal. Bioinformatics Analysis Identifies EPAS1 as a Novel Prognostic Marker Correlated with Immune Infiltration in Acute Myeloid Leukemia. Disease Markers 2023; 2023: 1 doi: 10.1155/2023/6072782
|
| 22 |
Ain Zubaidah Ayob, Thamil Selvee Ramasamy. Prolonged hypoxia switched on cancer stem cell-like plasticity in HepG2 tumourspheres cultured in serum-free media. In Vitro Cellular & Developmental Biology - Animal 2021; 57(9): 896 doi: 10.1007/s11626-021-00625-y
|
| 23 |
Ernestina Marianna De Francesco, Francesca Cirillo, Veronica Vella, Antonino Belfiore, Marcello Maggiolini, Rosamaria Lappano. Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress. Expert Opinion on Therapeutic Targets 2022; 26(6): 513 doi: 10.1080/14728222.2022.2094762
|
| 24 |
Hamid Lotfimehr, Narges Mardi, Samaneh Narimani, Hamid Tayefi Nasrabadi, Mohammad Karimipour, Emel Sokullu, Reza Rahbarghazi. mTORsignalling pathway in stem cell bioactivities and angiogenesis potential. Cell Proliferation 2023; 56(12) doi: 10.1111/cpr.13499
|
| 25 |
Karolina Kozal, Anna Krześlak. The Role of Hypoxia-Inducible Factor Isoforms in Breast Cancer and Perspectives on Their Inhibition in Therapy. Cancers 2022; 14(18): 4518 doi: 10.3390/cancers14184518
|
| 26 |
Ilhaam Ayaz Durrani, Peter John, Attya Bhatti, Jahangir Sarwar Khan. Network medicine based approach for identifying the type 2 diabetes, osteoarthritis and triple negative breast cancer interactome: Finding the hub of hub genes. Heliyon 2024; 10(17): e36650 doi: 10.1016/j.heliyon.2024.e36650
|
| 27 |
Zhuoling Zou, Tinglan Luo, Xinyuan Wang, Bin Wang, Qing Li. Exploring the interplay between triple‐negative breast cancer stem cells and tumor microenvironment for effective therapeutic strategies. Journal of Cellular Physiology 2024; 239(8) doi: 10.1002/jcp.31278
|
| 28 |
Binjie Huang, Xin Yan, Yumin Li. Cancer Stem Cell for Tumor Therapy. Cancers 2021; 13(19): 4814 doi: 10.3390/cancers13194814
|
| 29 |
Lochana Kovale, Manish Kumar Singh, Joungmok Kim, Joohun Ha. Role of Autophagy and AMPK in Cancer Stem Cells: Therapeutic Opportunities and Obstacles in Cancer. International Journal of Molecular Sciences 2024; 25(16): 8647 doi: 10.3390/ijms25168647
|
| 30 |
Hong-My Nguyen, Wyatt Paulishak, Mariam Oladejo, Laurence Wood. Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches. Breast Cancer 2023; 30(2): 167 doi: 10.1007/s12282-022-01415-4
|
| 31 |
Charles B. Nguyen, Eugene Oh, Piroz Bahar, Ulka N. Vaishampayan, Tobias Else, Ajjai S. Alva. Novel Approaches with HIF-2α Targeted Therapies in Metastatic Renal Cell Carcinoma. Cancers 2024; 16(3): 601 doi: 10.3390/cancers16030601
|
| 32 |
Stefania Nobili, Antonella Mannini, Astrid Parenti, Chiara Raggi, Andrea Lapucci, Giovanna Chiorino, Sara Paccosi, Paola Di Gennaro, Vania Vezzosi, Paolo Romagnoli, Tommaso Susini, Marcella Coronnello. Establishment and characterization of a new spontaneously immortalized ER−/PR−/HER2+ human breast cancer cell line, DHSF-BR16. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-87362-0
|
| 33 |
Sepideh Mirzaei, Hojjat Samareh Fekri, Farid Hashemi, Kiavash Hushmandi, Reza Mohammadinejad, Milad Ashrafizadeh, Ali Zarrabi, Manoj Garg. Venom peptides in cancer therapy: An updated review on cellular and molecular aspects. Pharmacological Research 2021; 164: 105327 doi: 10.1016/j.phrs.2020.105327
|
| 34 |
Wenmin Chen, Lu Zhang, Suling Liu, Ceshi Chen. Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells. Cells 2022; 11(19): 2941 doi: 10.3390/cells11192941
|
| 35 |
Zhi-Min Deng, Gan-Hong Chen, Fang-Fang Dai, Shi-Yi Liu, Dong-Yong Yang, An-Yu Bao, Yan-Xiang Cheng, Ritu Kulshreshtha. The clinical value of miRNA-21 in cervical cancer: A comprehensive investigation based on microarray datasets. PLOS ONE 2022; 17(4): e0267108 doi: 10.1371/journal.pone.0267108
|
| 36 |
Mohammed Hussein Assi. Hypoxia-inducible Factors: Molecular Basis and Clinical Implications. Mustansiriya Medical Journal 2023; 22(2): 161 doi: 10.4103/mj.mj_38_23
|
| 37 |
Wang Manni, Wu Min. Signaling pathways in the regulation of cancer stem cells and associated targeted therapy. MedComm 2022; 3(4) doi: 10.1002/mco2.176
|
| 38 |
Jingwei Xu, Di Xue, Yang Li, Jianwen Zhou, Hongyue Chen, Li Fan. Mechanisms of vemurafenib-induced anti-tumor effects in ATC FRO cells. Heliyon 2024; 10(6): e27629 doi: 10.1016/j.heliyon.2024.e27629
|
| 39 |
Yue Lu, Dongfang Cheng, Baohua Niu, Xiuzhi Wang, Xiaxia Wu, Aiping Wang. Properties of Poly (Lactic-co-Glycolic Acid) and Progress of Poly (Lactic-co-Glycolic Acid)-Based Biodegradable Materials in Biomedical Research. Pharmaceuticals 2023; 16(3): 454 doi: 10.3390/ph16030454
|
| 40 |
Mohammed Kaleem, Maryam Perwaiz, Suza Mohammad Nur, Abdulrasheed O. Abdulrahman, Wasim Ahmad, Fahad A. Al-Abbasi, Vikas Kumar, Mohammad Amjad Kamal, Firoz Anwar. Epigenetics of Triple-Negative Breast Cancer via Natural Compounds. Current Medicinal Chemistry 2022; 29(8): 1436 doi: 10.2174/0929867328666210707165530
|
| 41 |
Qi-Ying Yu, Zhi-Wen Wang, Meng-Ying Zhou, Shang-Fu Li, Xing-Hua Liao. MAGE-A3 regulates tumor stemness in gastric cancer through the PI3K/AKT pathway. Aging 2022; doi: 10.18632/aging.204373
|
| 42 |
Jing-Hua Liu, Wen-Ting Li, Yue Yang, Yan-Bo Qi, Yu Cheng, Jia-Hui Wu. MiR-526b-3p Attenuates Breast Cancer Stem Cell Properties and Chemoresistance by Targeting HIF-2α/Notch Signaling. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.696269
|
| 43 |
Gang Sun, Jin Zhang, Shuai Wu, Yun Liu. Experimental study on nuclear-targeted plasmid-based short hairpin RNA (ShRNA) to hypoxia inducible factor-1α (PshHIF-1α) PshHIF-1α nano-drug carrier system for breast cancer treatment in rats. Materials Express 2021; 11(7): 1045 doi: 10.1166/mex.2021.2029
|
| 44 |
Guangpeng He, Xueqiang Peng, Shibo Wei, Shuo Yang, Xinyu Li, Mingyao Huang, Shilei Tang, Hongyuan Jin, Jiaxing Liu, Sheng Zhang, Hongyu Zheng, Qing Fan, Jingang Liu, Liang Yang, Hangyu Li. Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications. Molecular Cancer 2022; 21(1) doi: 10.1186/s12943-021-01440-5
|
| 45 |
Yuanyuan Yan, Miao He, Lin Zhao, Huizhe Wu, Yanyun Zhao, Li Han, Binbin Wei, Dongman Ye, Xuemei Lv, Yan Wang, Weifan Yao, Haishan Zhao, Bo Chen, Zining Jin, Jian Wen, Yan Zhu, Tao Yu, Feng Jin, Minjie Wei. A novel HIF-2α targeted inhibitor suppresses hypoxia-induced breast cancer stemness via SOD2-mtROS-PDI/GPR78-UPRER axis. Cell Death & Differentiation 2022; 29(9): 1769 doi: 10.1038/s41418-022-00963-8
|
| 46 |
Nan Che, Zhaoting Yang, Xingzhe Liu, Mengxuan Li, Ying Feng, Chengye Zhang, Chao Li, Yan Cui, Yanhua Xuan. Suppression of LETM1 inhibits the proliferation and stemness of colorectal cancer cells through reactive oxygen species–induced autophagy. Journal of Cellular and Molecular Medicine 2021; 25(4): 2110 doi: 10.1111/jcmm.16169
|
| 47 |
Xing Zhen, Hack Sun Choi, Ji-Hyang Kim, Su-Lim Kim, Ren Liu, Yu-Chan Ko, Bong-Sik Yun, Dong-Sun Lee. Caudatin Isolated from Cynanchum auriculatum Inhibits Breast Cancer Stem Cell Formation via a GR/YAP Signaling. Biomolecules 2020; 10(6): 925 doi: 10.3390/biom10060925
|
| 48 |
Hui Xu, Fengxia Zhang, Xiaokang Gao, Qiwang Zhou, Linhai Zhu. Fate decisions of breast cancer stem cells in cancer progression. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.968306
|
| 49 |
Yiming Xu, Ziyi Bai, Tianxia Lan, Chenying Fu, Ping Cheng. CD44 and its implication in neoplastic diseases. MedComm 2024; 5(6) doi: 10.1002/mco2.554
|
| 50 |
Dingwen Zhong, Yonghui Liao, Wenhui Chen, Xianyu Huang, Jiaxin Liu, Zheng Wang. TYROBP promotes the spread of pancreatic cancer by causing M2 TAM polarization. Journal of Gastroenterology and Hepatology 2024; 39(12): 2926 doi: 10.1111/jgh.16783
|
| 51 |
Yiming Yang, Xiaohui Liu, Yang Zhang, Hao Dai, Jianglun Shen, Fen Hu, Haifeng Cai, Jinyin Yan. Superparamagnetic Iron Oxide Nanoparticles Directed miRNA-34b-RNA-Binding Proteins T Cell to Restrict Intracellular Antigen-1-Stress Granules (TIA-1-SG) in Breast Cancer Chemotherapy. Science of Advanced Materials 2021; 13(10): 1865 doi: 10.1166/sam.2021.4100
|
| 52 |
Hamid A. Bakshi, Michella Mkhael, Hakkim L. Faruck, Asad Ullah Khan, Alaa A.A. Aljabali, Vijay Mishra, Mohamed El-Tanani, Nitin B. Charbe, Murtaza M. Tambuwala. Cellular signaling in the hypoxic cancer microenvironment: Implications for drug resistance and therapeutic targeting. Cellular Signalling 2024; 113: 110911 doi: 10.1016/j.cellsig.2023.110911
|